Kawasaki Kisen Kaisha Ltd
F:KLI1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kawasaki Kisen Kaisha Ltd
F:KLI1
|
JP |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
US |
|
B
|
Banco Santander SA
DUS:BSD2
|
ES |
|
A
|
ALK-Abello A/S
F:4AJ
|
DK |
Wall St Price Targets
KLI1 Price Targets Summary
Kawasaki Kisen Kaisha Ltd
According to Wall Street analysts, the average 1-year price target for KLI1 is 11.52 EUR with a low forecast of 6.17 EUR and a high forecast of 14.49 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KLI1's stock price target?
Price Target
11.52
EUR
According to Wall Street analysts, the average 1-year price target for KLI1 is 11.52 EUR with a low forecast of 6.17 EUR and a high forecast of 14.49 EUR.
What is the Revenue forecast for Kawasaki Kisen Kaisha Ltd?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 0%.
What is the Operating Income forecast for Kawasaki Kisen Kaisha Ltd?
Projected CAGR
-7%
The compound annual growth rate for Operating Income over the next 10 years is -7%.
What is the Net Income forecast for Kawasaki Kisen Kaisha Ltd?
Projected CAGR
-29%
The compound annual growth rate for Net Income over the next 3 years is -29%.
